Design Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Design Therapeutics Total Assets Growth & History (DSGN)
Design Therapeutics's total assets was $226.2M for fiscal 2025.
View full Design Therapeutics company overviewDesign Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $226.2M | −$25.9M | −10.27% |
| 2024 | 2024-12-31 | $252.1M | −$37.5M | −12.96% |
| 2023 | 2023-12-31 | $289.6M | −$51.5M | −15.09% |
| 2022 | 2022-12-31 | $341.1M | −$49.4M | −12.65% |
| 2021 | 2021-12-31 | $390.6M | $354.0M | +969.55% |
| 2020 | 2020-12-31 | $36.5M | — | — |
Design Therapeutics quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $215.1M | −$7.8M | −3.48% |
| Q1 2026 | 2026-03-31 | $230.4M | −$7.0M | −2.96% |
| Q4 2025 | 2025-12-31 | $226.2M | −$25.9M | −10.27% |
| Q3 2025 | 2025-09-30 | $211.8M | −$49.9M | −19.06% |
| Q2 2025 | 2025-06-30 | $222.9M | −$46.7M | −17.32% |
| Q1 2025 | 2025-03-31 | $237.5M | −$41.3M | −14.82% |
| Q4 2024 | 2024-12-31 | $252.1M | −$37.5M | −12.96% |
| Q3 2024 | 2024-09-30 | $261.6M | −$38.2M | −12.75% |
| Q2 2024 | 2024-06-30 | $269.6M | −$42.0M | −13.49% |
| Q1 2024 | 2024-03-31 | $278.8M | −$46.0M | −14.15% |
| Q4 2023 | 2023-12-31 | $289.6M | −$51.5M | −15.09% |
| Q3 2023 | 2023-09-30 | $299.9M | −$54.7M | −15.43% |
| Q2 2023 | 2023-06-30 | $311.6M | −$56.3M | −15.30% |
| Q1 2023 | 2023-03-31 | $324.7M | −$54.1M | −14.27% |
| Q4 2022 | 2022-12-31 | $341.1M | −$49.4M | −12.65% |
| Q3 2022 | 2022-09-30 | $354.6M | −$45.8M | −11.44% |
| Q2 2022 | 2022-06-30 | $367.9M | −$37.2M | −9.19% |
| Q1 2022 | 2022-03-31 | $378.8M | −$33.1M | −8.03% |
| Q4 2021 | 2021-12-31 | $390.6M | $354.0M | +969.55% |
| Q3 2021 | 2021-09-30 | $400.4M | — | — |
| Q2 2021 | 2021-06-30 | $405.1M | — | — |
| Q1 2021 | 2021-03-31 | $411.9M | — | — |
| Q4 2020 | 2020-12-31 | $36.5M | — | — |
Design Therapeutics total assets trends
Over the last five fiscal years, Design Therapeutics's total assets increased from $36.5M to $226.2M, a change of $189.7M. The latest reported quarter, Q2 2026, shows $215.1M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Design Therapeutics source filings ↗